1. Home
  2. XYLO vs RSLS Comparison

XYLO vs RSLS Comparison

Compare XYLO & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • RSLS
  • Stock Information
  • Founded
  • XYLO 1999
  • RSLS 2002
  • Country
  • XYLO Israel
  • RSLS United States
  • Employees
  • XYLO N/A
  • RSLS N/A
  • Industry
  • XYLO
  • RSLS Medical/Dental Instruments
  • Sector
  • XYLO
  • RSLS Health Care
  • Exchange
  • XYLO NYSE
  • RSLS Nasdaq
  • Market Cap
  • XYLO 3.8M
  • RSLS 4.5M
  • IPO Year
  • XYLO N/A
  • RSLS 2007
  • Fundamental
  • Price
  • XYLO $4.84
  • RSLS $4.18
  • Analyst Decision
  • XYLO
  • RSLS Hold
  • Analyst Count
  • XYLO 0
  • RSLS 1
  • Target Price
  • XYLO N/A
  • RSLS N/A
  • AVG Volume (30 Days)
  • XYLO 1.5K
  • RSLS 3.1M
  • Earning Date
  • XYLO 06-17-2025
  • RSLS 05-21-2025
  • Dividend Yield
  • XYLO N/A
  • RSLS N/A
  • EPS Growth
  • XYLO N/A
  • RSLS N/A
  • EPS
  • XYLO N/A
  • RSLS N/A
  • Revenue
  • XYLO $29,858,000.00
  • RSLS $7,175,000.00
  • Revenue This Year
  • XYLO $279.19
  • RSLS $52.80
  • Revenue Next Year
  • XYLO N/A
  • RSLS N/A
  • P/E Ratio
  • XYLO N/A
  • RSLS N/A
  • Revenue Growth
  • XYLO N/A
  • RSLS N/A
  • 52 Week Low
  • XYLO $2.70
  • RSLS $4.03
  • 52 Week High
  • XYLO $6.67
  • RSLS $414.99
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 41.82
  • RSLS 38.80
  • Support Level
  • XYLO $4.79
  • RSLS $4.03
  • Resistance Level
  • XYLO $5.26
  • RSLS $8.29
  • Average True Range (ATR)
  • XYLO 0.12
  • RSLS 0.77
  • MACD
  • XYLO -0.04
  • RSLS 0.24
  • Stochastic Oscillator
  • XYLO 10.20
  • RSLS 3.52

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About RSLS ReShape Lifesciences Inc.

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.

Share on Social Networks: